The New York Times, November 6, 2026
A tech start-up made a splash last month with a remarkable announcement: Its researchers had used artificial intelligence to design viruses tailored to kill the bacteria causing a dangerous infection. Those viruses were used to treat a sick patient.
The disclosure, in a blog post on the company’s site, drew cautious curiosity from experts and coverage in The New York Times. But now the company, Radical Numerics, has acknowledged that it did not work alone.
Continue reading “Biotech Firm Claims Some Credit for Groundbreaking Virus Research”